Zhejiang Jiuzhou Pharmaceutical saw the highest growth of 1.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.19% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Zhejiang Jiuzhou Pharmaceutical’s patent filings and grants. Buy the databook here.
Zhejiang Jiuzhou Pharmaceutical has been focused on protecting inventions in China(CN) with six publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN) patent Office are among the top ten patent offices where Zhejiang Jiuzhou Pharmaceutical is filings its patents. Among the top granted patent authorities, Zhejiang Jiuzhou Pharmaceutical has 100% of its grants in China(CN).
Fujifilm could be the strongest competitor for Zhejiang Jiuzhou Pharmaceutical
Patents related to climate change lead Zhejiang Jiuzhou Pharmaceutical's portfolio
Zhejiang Jiuzhou Pharmaceutical has the highest number of patents in climate change. For climate change no patents were filed and 100% of patents were granted in Q2 2024.
Petrochemicals related patents lead Zhejiang Jiuzhou Pharmaceutical portfolio followed by manufacturing/industrial
Zhejiang Jiuzhou Pharmaceutical has highest number of patents in petrochemicals followed by manufacturing/industrial.
For comprehensive analysis of Zhejiang Jiuzhou Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.